We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes.
- Authors
Gaudy, Caroline; Clévy, Céline; Monestier, Sandrine; Dubois, Noémie; Préau, Yanis; Mallet, Stéphanie; Richard, Marie-Aleth; Grob, Jean-Jacques; Valéro, René; Béliard, Sophie
- Abstract
The article presents research which focused on the possibility that anti-PD1 pembrolizumab induces type 1 diabetes. Topics covered include the function of pembrolizumab as a monoclonal antibody that prevents PD1. Also mentioned is the importance of the antibody to enhance the survival of diabetes patients.
- Subjects
PEMBROLIZUMAB; PEOPLE with diabetes; APOPTOSIS prevention; MONOCLONAL antibodies; SURVIVAL analysis (Biometry); THERAPEUTICS
- Publication
Diabetes Care, 2015, Vol 38, Issue 11, pe182
- ISSN
0149-5992
- Publication type
letter
- DOI
10.2337/dc15-1331